361
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii

, &
Pages 1099-1111 | Published online: 07 May 2019

References

  • Mezzatesta ML, Trovato G, Gona F, et al. In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant acinetobacter baumannii clinical isolates in Italy. Ann Clin Microbiol Antimicrob. 2008;7:4. doi:10.1186/1476-0711-7-418261233
  • Longo F, Vuotto C, Donelli G. Biofilm formation in acinetobacter baumannii. New Microbiol. 2014;37(2):119–127.24858639
  • Stewart PS. Antimicrobial Tolerance in Biofilms. Microbiol Spectr. 2015;3:3. doi:10.1128/microbiolspec.MB-0010-2014
  • Selasi GN, Nicholas A, Jeon H, et al. Differences in biofilm mass, expression of biofilm-associated genes, and resistance to desiccation between epidemic and sporadic clones of carbapenem-resistant acinetobacter baumannii sequence type 191. PLoS One. 2016;11(9):e0162576. doi:10.1371/journal.pone.016257627622249
  • Luo LM, Wu LJ, Xiao YL, et al. Enhancing pili assembly and biofilm formation in acinetobacter baumannii ATCC19606 using non-native acyl-homoserine lactones. BMC Microbiol. 2015;15:62. doi:10.1186/s12866-015-0397-525888221
  • Gaddy JA, Actis LA. Regulation of acinetobacter baumannii biofilm formation. Future Microbiol. 2009;4(3):273–278. doi:10.2217/fmb.09.519327114
  • Alav I, Sutton JM, Rahman KM. Role of bacterial efflux pumps in biofilm formation. J Antimicrob Chemother. 2018;73(8):2003–2020. doi:10.1093/jac/dky04229506149
  • Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev. 2014;78(3):510–543. doi:10.1128/MMBR.00013-1425184564
  • Majtán J, Majtánová L, Xu M, Majtán V. In vitro effect of subinhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar typhimurium isolated in Slovakia. J Appl Microbiol. 2008;104(5):1294–1301. doi:10.1111/j.1365-2672.2007.03653.x18028358
  • Denève C, Bouttier S, Dupuy B, Barbut F, Collignon A, Janoir C. Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains. Antimicrob Agents Chemother. 2009;53(12):5155–5162. doi:10.1128/AAC.00532-0919805572
  • Zhou L, Li T, An J, Liao C, Li N, Wang X. Subminimal inhibitory concentration (sub-MIC) of antibiotic induces electroactive biofilm formation in bioelectrochemical systems. Water Res. 2017;125:280–287. doi:10.1016/j.watres.2017.08.05928866443
  • Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011;34(9):737–751. doi:10.5301/ijao.500002722094552
  • Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55(11):4943–4960. doi:10.1128/AAC.00296-1121859938
  • Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2(3):291–304. doi:10.4103/0974-777X.6853820927292
  • Chiotos K, Ross RK, Han JH, Miller M, Gerber JS. Use of carbapenems, polymyxins, and tigecycline in United States Children’s Hospitals, 2010–2014. Open Forum Infect Dis. 2017;4(2):ofx039. doi:10.1093/ofid/ofx03928470018
  • Sato Y, Unno Y, Ubagai T, Ono Y. Sub-minimum inhibitory concentrations of colistin and polymyxin B promote acinetobacter baumannii biofilm formation. PLoS One. 2018;13(3):e0194556. doi:10.1371/journal.pone.019455629554105
  • Hall GS. Non-fermenting and miscellaneous gram-negative bacilli In: Mahon CR, Lehman DC, Manuselis G, editors. Textbook of Diagnostic Microbiology. Maryland Heights, MO: Saunders/Elsevier; 2011:482–501.
  • Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44:2974–2976. doi:10.1128/JCM.01021-0616891520
  • Qi L, Li H, Zhang C, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in acinetobacter baumannii. Front Microbiol. 2016;7:483. doi:10.3389/fmicb.2016.0048327148178
  • Zhang D, Xia J, Xu Y, et al. Biological features of biofilm-forming ability of acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia. Clin Exp Med. 2016;16(1):73–80. doi:10.1007/s10238-014-0333-225543268
  • CLSI. M100-S28. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Eight Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
  • Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol. 2007;45:227–230. doi:10.1128/JCM.01588-0617093026
  • He X, Lu F, Yuan F, et al. Biofilm formation caused by clinical acinetobacter baumannii isolates is associated with overexpression of the AdeFGH efflux pump. Antimicrob Agents Chemother. 2015;59(8):4817–4825. doi:10.1128/AAC.00877-1526033730
  • López M, Mayer C, Fernández-García L, et al. Quorum sensing network in clinical strains of A. baumannii: aidA is a new quorum quenching enzyme. PLoS One. 2017;12(3):e0174454. doi:10.1371/journal.pone.017445428328989
  • Smaldone G, Marrone R, Cappiello S, et al. Occurrence of antibiotic resistance in bacteria isolated from seawater organisms caught in Campania Region: preliminary study. BMC Vet Res. 2014;10:161. doi:10.1186/1746-6148-10-125027759
  • Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484. doi:10.1128/AAC.01464-0617646423
  • Lin MF, Lan CY. Antimicrobial resistance in acinetobacter baumannii: from bench to bedside. World J Clin Cases. 2014;2(12):787–814. doi:10.12998/wjcc.v2.i12.78725516853
  • Jamal S, Al Atrouni A, Rafei R, Dabboussi F, Hamze M, Osman M. Molecular mechanisms of antimicrobial resistance in acinetobacter baumannii, with a special focus on its epidemiology in Lebanon. J Glob Antimicrob Resist. 2018;15(12):154–163. doi:10.1016/j.jgar.2018.05.02229859266
  • Hujer KM, Hujer AM, Hulten EA, et al. Analysis of antibiotic resistance genes in multidrug-resistant acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006;50:4114–4123. doi:10.1128/AAC.00778-0617000742
  • Singh S, Singh SK, Chowdhury I, Singh R. Understanding the Mechanism of bacterial biofilms resistance to antimicrobial agents. Open Microbiol J. 2017;11:53–62. doi:10.2174/187428580171101005328553416
  • Wood TK, Knabel SJ, Kwan BW. Bacterial persister cell formation and dormancy. Appl Environ Microbiol. 2013;79(23):7116–7121. doi:10.1128/AEM.02636-1324038684
  • Hawkey PM, Livermore DM. Carbapenem antibiotics for serious infections. BMJ. 2012;344:e3236. doi:10.1136/bmj.e323622654063
  • Maestre JR, Aguilar L, Mateo M, et al. In vitro interference of tigecycline at subinhibitory concentrations on biofilm development by Enterococcus faecalis. J Antimicrob Chemother. 2012;67(5):1155–1158. doi:10.1093/jac/dks01422323499
  • Chen H, Cao J, Zhou C, Liu H, Zhang X, Zhou T. Biofilm formation restrained by subinhibitory concentrations of tigecyclin in acinetobacter baumannii is associated with downregulation of efflux pumps. Chemotherapy. 2017;62(2):128–133. doi:10.1159/00045053727816975
  • Szczuka E, Jablonska L, Kaznowski A. Effect of subinhibitory concentrations of tigecycline and ciprofloxacin on the expression of biofilm-associated genes and biofilm structure of staphylococcus epidermidis. Microbiology. 2017;163(5):712–718. doi:10.1099/mic.0.00045328481197
  • Weiser J, Henke HA, Hector N, et al. Sub-inhibitory tigecycline concentrations induce extracellular matrix binding protein Embp dependent staphylococcus epidermidis biofilm formation and immune evasion. Int J Med Microbiol. 2016;306(6):471–478. doi:10.1016/j.ijmm.2016.05.01527292911
  • Bhargava N, Sharma P, Capalash N. Quorum sensing in acinetobacter: an emerging pathogen. Crit Rev Microbiol. 2010;36(4):349–360. doi:10.3109/1040841X.2010.51226920846031
  • Kvist M, Hancock V, Klemm P. Inactivation of efflux pumps abolishes bacterial biofilm formation. Appl Environ Microbiol. 2008;74(23):7376–7382. doi:10.1128/AEM.01310-0818836028
  • Yoon EJ, Courvalin P, Grillot-Courvalin C. RND-type efflux pumps in multidrug-resistant clinical isolates of acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother. 2013;57(7):2989–2995. doi:10.1128/AAC.02556-1223587960
  • Yang YS, Chen HY, Hsu WJ, et al. Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical acinetobacter nosocomialis isolates. Clin Microbiol Infect. 2018;pii: S1198–743X(18):30473–30477. doi:10.1016/j.cmi.2018.06.012
  • Damier-Piolle L, Magnet S, Brémont S, Lambert T, Courvalin P. AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in acinetobacter baumannii. Antimicrob Agents Chemother. 2008;52(2):557–562. doi:10.1128/AAC.00732-0718086852
  • Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003;149(Pt 12):3473–3484. doi:10.1099/mic.0.26541-014663080
  • Pakharukova N, Tuittila M, Paavilainen S, et al. Structural basis for acinetobacter baumannii biofilm formation. Proc Natl Acad Sci U S A. 2018;115(21):5558–5563. doi:10.1073/pnas.180096111529735695
  • Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009;191(19):5953–5963. doi:10.1128/JB.00647-0919633088
  • Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun. 2009;77(8):3150–3160. doi:10.1128/IAI.00096-0919470746
  • Brossard KA, Campagnari AA. The acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun. 2012;80(1):228–233. doi:10.1128/IAI.05913-1122083703